Company / Current Liabilities per Share
ResMed Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$6.94
FY2025
5-year range
$4.73 / $6.94
FY2021-FY2025
Trend
+12.0%
vs FY2024
Sector context
#66 of 163
Health Care
What the data says
At $6.94, ResMed's current liabilities per share ranks #98 of 163 in the Health Care sector. Current Liabilities per Share has increased for 3 consecutive years, from $4.73 in FY2022 to $6.94 in FY2025.
Based on SEC 10-K filings.
6.94 in FY2025 with a 5-year CAGR of +10.6%.
Increased from $5.18 to $6.94 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +13.6%
- 5-Year CAGR
- +10.6%
- 10-Year CAGR
- -
Sector benchmark
#98 of 163 in Health CareTop 60% of 163This company $6.94 Sector average $29.06
▼
-76.1% below sector average
Key checks
Key Insights
- ResMed's current liabilities per share has grown for 3 consecutive years.
- In FY2025, current liabilities per share increased 12.0% year-over-year.
- Ranks #66 out of 163 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2017.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.94 | +12.0% |
| FY2024 | $6.19 | +19.5% |
| FY2023 | $5.18 | +9.5% |
| FY2022 | $4.73 | -24.8% |
| FY2021 | $6.29 | +50.0% |
| FY2020 | $4.20 | +7.7% |
| FY2019 | $3.90 | +8.4% |
| FY2018 | $3.60 | +40.5% |
| FY2017 | $2.56 | -43.6% |
| FY2016 | $4.54 | +139.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026